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Lactobacilli are widely used as probiotics with beneficial effects on infection-associated 
diarrhea, but also used in clinical trials of e.g., necrotizing enterocolitis and inflamma-
tory bowel diseases. The possibility of using probiotic metabolic products, so-called 
postbiotics, is desirable as it could prevent possible side effects of live bacteria in indi-
viduals with a disturbed gut epithelial barrier. Here, we studied how Lactobacillus reuteri 
DSM 17938 cell-free supernatant (L. reuteri-CFS) influenced retinoic acid (RA)-driven 
mucosal-like dendritic cells (DC) and their subsequent effect on T regulatory cells (Treg) 
in vitro. RA clearly imprinted a mucosal-like DC phenotype with higher IL10 production, 
increased CD103 and CD1d expression, and a downregulated mRNA expression of 
several inflammatory-associated genes (NFκB1, RELB, and TNF). Treatment with 
L. reuteri-CFS further influenced the tolerogenic phenotype of RA-DC by downregulating 
most genes involved in antigen uptake, antigen presentation, and signal transduction as 
well as several chemokine receptors, while upregulating IL10 production. L. reuteri-CFS 
also augmented CCR7 expression on RA-DC. In cocultures, RA-DC increased IL10 and 
FOXP3 expression in Treg, but pre-treatment with L. reuteri-CFS did not further influence 
the Treg phenotype. In conclusion, L. reuteri-CFS modulates the phenotype and function 
of mucosal-like DC, implicating its potential application as postbiotic.
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inTrODUcTiOn
The mucosal immune system in the gut is continuously exposed to innocuous dietary antigens and com-
mensal microbes. Apart from its well-known effects on gut homeostasis and metabolic functions, this 
local microenvironment plays a major role in shaping the response of immune cells in their specialized 
tissue-associated functions; for instance intestinal epithelial cells influence the gut dendritic cells (DC) 
response, which subsequently influence T cell responses. Factors such as thymic stromal lymphopoietin 
and indoleamine 2,3-dioxygenase produced by epithelial cells confer a tolerogenic phenotype on DC 
(1). Epithelial cells have also been shown to metabolize vitamin A into retinoic acid (RA) (2). Among its 
pleiotropic effects, RA has been shown to promote the migration of pre-DC, the precursor of CD103+ DC, 
to the small intestine (3) and to induce CD103+ expression in monocyte derived (Mo-) DC in vitro (4). 
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Coculturing RA-DC with T cells induces upregulation of the gut 
homing markers CCR9 and α4β7, and constitutive production of 
IL10 in T cells (5, 6). But the response of RA-DC to gut microbes 
has not yet been evaluated in vitro.
Although usually present in low numbers, lactobacilli are 
common inhabitants of the human gut, in particular in early 
life (7). Lactobacilli seem capable of modulating both mucosal 
and systemic immune responses, but the effects on the immune 
system vary between strains (8), and some lactobacilli are able to 
induce the production of both pro-inflammatory and regulatory 
cytokines, such as IL6, TNF-α, and IL10 (9, 10). Due to their gen-
erally accepted health benefits, lactobacilli are widely consumed 
as probiotics and their therapeutic potential has been considered 
for future treatment of several disorders (11–15).
One of the most commercially and clinically recognized 
Lactobacillus strain is Lactobacillus reuteri DSM 17938 
(L. reuteri 17938) (16). L. reuteri DSM 17938 is derived from 
L. reuteri ATCC 55730, isolated from a Peruvian mother’s breast 
milk. Two plasmids harboring antibiotic resistance genes were 
removed from strain 55730 to obtain strain 17938, which inhibits 
pathogen growth and modulates the immune system (17). It has 
been shown that feeding L. reuteri DSM 17938 to newborn rats 
in an animal model of necrotizing enterocolitis (NEC) induced a 
strong anti-inflammatory effect through inhibiting TLR4 signal-
ing pathway in the intestine (18). This resulted in a reduction of 
the severity of the disease by modulation of the balance between 
T effector/memory (Tem) cells and regulatory T (Treg) cells (19).
Although most of its effects require direct bacteria–host cell 
contact, some lactobacilli-produced soluble factors have also 
been shown to modulate the immune response. Understanding 
the mechanisms by which soluble factors produced by probiot-
ics, recently termed postbiotics, modulate immune function 
may be vital to develop alternative therapeutic techniques (20). 
The aim of this study was to elucidate the influence of L. reuteri 
17938 cell-free supernatant (CFS) on the response of RA-DC. 
We further investigated how RA-treatment of DC as well as 
L. reuteri-exposure influenced subsequent T cell responses.
MaTerials anD MeThODs
Lactobacillus reuteri DsM 17938
A CFS from Lactobacillus (L.) reuteri DSM 17938 (Biogaia AB, 
Stockholm, Sweden) was kindly provided by Stefan Roos, the 
Swedish University of Agricultural Sciences. L. reuteri DSM 17938 
was cultured in MRS broth (Oxoid, Hampshire, UK) at 37°C for 
20 h (still culture). The CFS was removed from the bacterial pellet 
by centrifugation at 14,000 g. The supernatant was sterile filtered 
(0.2 μm) and stored at −20°C until used. Before stimulation of 
DC, the L. reuteri-CFS was diluted 1:1 with HEPES to keep the 
pH at 7.2–7.5 (21).
generation and activation of immature 
ra-Dc and Mo-Dc from cD14+ 
Monocytes
Peripheral blood mononuclear cells (PBMC) were isolated 
from buffy coats from healthy blood donors using Ficoll 
(GE Healthcare, Logan, UT, USA) gradient centrifugation. CD14+ 
monocytes were enriched by negative selection using EasySep™ 
human monocyte enrichment kit (STEMCELL™ Technologies, 
Grenoble, France) according to the manufacturer’s protocol. The 
4 × 105 cells/ml of the enriched monocytes were seeded in 6-well 
plates in complete culture medium (RPMI-1640, GE Healthcare), 
10% heat-inactivated fetal bovine serum (Gibco-Invitrogen, 
Waltham, MA, USA), 1% l-glutamine (GE Healthcare), 1% 
penicillin–streptomycin (Thermo Scientific, Waltham, MA, 
USA), 2% sodium pyruvate (Gibco-Invitrogen), 2% HEPES buffer 
(GE Healthcare), and 50 μM β-mercaptoethanol (Sigma-Aldrich, 
St Louis, MO, USA), supplemented by 25  ng/ml rHuGM-CSF 
and 20  ng/ml rHuIL4 (both from Peprotech Inc., Rocky Hill, 
NJ, USA). To generate RA-DC, 1.15 μg/ml RA (Sigma-Aldrich) 
was also added once to the monocyte cultures. On day 3, the 
cultures were refreshed with new media, supplemented with IL4, 
GM-CSF, and RA.
On day 6, RA-DC and Mo-DC were further stimulated with 
5% L. reuteri-CFS for 24 h. As controls, cells were stimulated with 
ultrapure LPS-0111:B4 (500 ng/ml) (InvivoGen, San Diego, CA, 
USA) or were kept in culture medium. Culture supernatants from 
the 24 h-stimulations were collected and stored at −20°C until 
further analysis. The cells were used for surface staining.
All experiments were approved by the Regional Ethics 
Committee in Stockholm (Dnr 2014/2052-32). All study sub-
jects gave their informed written consent, and all samples were 
coded and stored and used as stated in the approved ethical 
application. It is not possible to connect published data to any 
individual.
gene expression Profiling of ra-Dc and 
Mo-Dc Using rT2 Profiler™ Pcr array
Gene expression profile in Mo-DC and RA-DC was investigated 
by using the RT2 Profiler™ PCR Array Human Dendritic and 
Antigen Presenting Cell (PAHS-406ZF) (Qiagen, Germantown, 
MD, USA) following stimulation with L. reuteri-CFS or LPS 
for 24 h. The 1.50 × 106 Stimulated DC cells were homogenized 
with QIAshredder® (Qiagen) and total RNA was isolated with 
the RNeasy® Mini Kit (Qiagen). The amount, purity, and qual-
ity of the generated RNA were evaluated using a NanoDrop™ 
8-sample spectrophotometer (Thermo Scientific) and an Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). 
Only RNA samples with a RNA integrity number (RIN) >  8.5 
were used for gene expression analysis. The RT2 First Strand 
Kit (Qiagen) was used to generate cDNA, starting with 0.5 μg 
of total RNA for each sample. Quantitative polymerase chain 
reactions were performed using the RT2 SYBR Green ROX qPCR 
Mastermix as recommended by the manufacturer (Qiagen), and 
the array was run with the LightCycler® 480 real-time PCR (Roche 
Applied Science, Penzberg, Germany). Results were analyzed 
in the web-based GeneGlobe Data Analysis Center (Qiagen). 
Gene expression levels were normalized to the reference genes: 
ribosomal protein, large, P0 (RPLPO), and glyceraldehydes-
3-phosphate dehydrogenase (GAPDH). The reference genes were 
selected based on their stability in expression among samples 
(CT difference <1).
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staining and Flow cytometry analysis of 
ra-Dc and Mo-Dc
RA-DC and Mo-DC were stained with the following monoclonal 
antibodies: CD14 FITC-A (clone M5E2), CD1d PE-A (clone 
CD1d42), CD86 PerCP-A (clone IT2.2), CD83 PE-Cy7-A (clone 
HBI5e), CD11c APC-A (clone B-ly6), CD103 PE-A (clone Ber-
ACT8), HLA-DR PerCP-A (clone G46-6), DC-SIGN BV421-A 
(clone DCN46) (all from BD Biosciences, San Jose, CA, USA), 
and CCR7 BV421-A (clone G043H7) (BioLegend, San Diego, 
CA, USA). The FACSVerse instrument and the FACS Suite soft-
ware (BD Biosciences) were used to acquire data. Corresponding 
isotype-matched antibodies were used as negative controls. 
Detailed gating strategies for the DC can be found in Figure S1A 
in Supplementary Material. The results show either the percent-
age of positive cells within a given population or the mean surface 
expression of receptors per cell defined as geometrical mean 
fluorescence intensity (MFI). Analysis was done with FlowJo 
Software (TreeStar, Ashland, OR, USA) and Cytobank (Cytobank, 
Inc., Mountain View, CA, USA).
cytokine analysis (elisa)
Levels of IL6, IL10, IL12, IL23, TGFβ1, and TNFα in the DC 
culture medium were measured with enzyme-linked immuno-
sorbent assays (ELISA) kits (MabTech, Nacka, Sweden). In short, 
plates were coated for 24 h, washed, and blocked with BSA 0.1% 
v/v in PBS with 0.05% Tween. The DC supernatant was added 
and incubated overnight. Biotin-labeled secondary antibodies 
and streptavidin-ALP were then added prior to the phosphate 
substrate (Sigma-Aldrich). The optical density was determined 
using a micro-plate reader (Molecular Devices Corp., Sunnyvale, 
CA, USA) set at 405 nm. Results were analyzed using SoftMax Pro 
5.2 rev C (Molecular Devices Corp.).
chemokine array
Human chemokine array kit (Abcam, Cambridge, UK) was used 
to detect 38 chemokines simultaneously in supernatants from 
Mo-DC and RA-DC after stimulation. The antibody-coated 
nitrocellulose membranes were incubated with blocking buffer 
for 30 min. DC-supernatants from each sample were diluted 1:1 
with blocking buffer, added to the membranes and incubated 
on a rocking platform at 2–8°C overnight. After washing the 
membranes, a cocktail of biotin-conjugated anti-chemokine 
antibodies was added in to each membrane and incubated for 
2 h, followed by repetitive washing. After 2 h of incubation with 
streptavidin-HRP, each nitrocellulose membrane was rinsed and 
exposed to detection buffer for 1 min to develop chemilumines-
cent spots. Images were captured using a luminescent image ana-
lyzer (Fujifilm, LAS-100 plus, Tokyo, Japan). In order to quickly 
identify the positive signals on developed image, a transparent 
overlay template was placed on the array image film and aligned 
with the pairs of reference spots in each array. The spot intensity 
was qualitatively compared among the groups.
T cells coculture with ra-Dc and Mo-Dc 
Pre-conditioned with L. reuteri-cFs
RA-DC and Mo-DC were stimulated for 5 h with 5% L. reuteri-
CFS. Prior to coculture with T cells, the stimulated DC were 
washed three times with complete culture medium to prevent 
carry-over of L. reuteri-CFS to the coculture. Autologous T cells 
were negatively selected from PBMC with the EasySep™ Human 
T Cell Enrichment Kit (STEMCELL™ Technologies) according 
to the manufacturer’s instructions. T cell purity was 95.9% as 
determined by flow cytometry. DC and T cells were cocultured 
in a 1:4 ratio (DC:T cell) for 24 h without additional stimuli. The 
cells were used for flow cytometry analysis.
staining and Flow cytometry analysis of  
T cells
Following coculture with RA-DC and Mo-DC, T cells were 
stained for surface and intracellular markers using CD3 Pecy7-A 
(clone SK7), CD25 BV421-A (clone BC96) and IL10 APC-A 
(clone JES3-pD7) (all from BioLegend), CD4 FITC-A (clone 
RPA-T4), CD8 APC-H7-A (clone SK1), and FoxP3 PE-A (clone 
259D/C7) (all from BD Biosciences). Live/dead fixable dead cell 
stain kit Aqua-A (Life Technologies, Eugene, OR, USA) was 
included in all panels. For the intracellular staining of FoxP3 and 
IL10, monensin (BD Biosciences) was added to the coculture 
5 h before analysis and then cells were fixed and permeabilized 
prior to intracellular staining. Corresponding isotype-matched 
antibodies were used as negative controls. Detailed gating strate-
gies can be found in Figure S1B in Supplementary Material. The 
FACS analysis was performed as mentioned above.
statistics
To assess differences between immature Mo-DC and immature 
RA-DC or between stimulated and the unstimulated DC, the 
obtained raw data was log-transformed. The normal distribution 
of the log transformed was tested using D’Agostino–Pearson 
Omnibus or Shapiro–Wilk normality test. If the data pass the 
normality test, the log-transformed data were analyzed with 
one-way ANOVA. If differences among groups were significant, 
Bonferroni multiple comparisons-test was performed to control 
for multiple comparisons and confirm the p-values between paired 
groups. If the data were not normally distributed, Kruskal–Wallis 
ANOVA was used to investigate differences among the groups. 
When significant, the Mann–Whitney U-test was further used 
to investigate differences between groups. All statistical com-
putations were performed using GraphPad Prism software V6 
(La Jolla, CA, USA).
resUlTs
enhanced expression of gut  
homing-associated genes and reduced 
expression of genes associated with 
inflammation in ra-Dc
To unravel the broad impacts of RA on the DC phenotype, we 
measured the expression of an array of DC-associated genes in 
RA-DC and Mo-DC. Genes for IL6, IL10, and CD1d were upregu-
lated in the RA-DC population. Apart from this, most other genes 
that differed in expression between RA-DC and Mo-DC genes were 
less expressed in RA-DC (Figure 1, Table S1 in Supplementary 
Material). There was a downregulation of mRNA expression for 
FigUre 1 | ra treatment imprints down-regulation in gene expression 
of dendritic cells. RT2 PCR arrays were performed on the RNA extracted 
from RA-DC and Mo-DC at day 6 of culture. Scatter plots shows the fold 
change of the gene expression of the RA-DC in culture medium in 
comparison to that of the Mo-DC in culture medium. Upregulated genes are 
shown in yellow, downregulated genes are shown in blue, and unchanged 
(less than twofold change) genes in black.
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several factors in RA-DC with key functions in an inflammatory 
setting, like IL12b, IFNG, TNF, RELB, and NFκB1. Further, several 
genes associated with antigen presentation and T cell interactions 
were downregulated, like CD74, CD80, HLA-DMA, HLA-DPA, 
CD1A, CD1B, and CD1C. Gene expression of molecules associ-
ated with transmigration and gut homing like ICAM1 and ICAM2 
were upregulated in RA-DC together with some chemokines 
such as CCL2, CCL5, and CCL7. Still, the expression of other 
chemokines, including CCL19, CXCL1, CXCL10, and CXCL2 was 
downregulated. In addition, RA-DC had a lower expression of the 
chemokine receptors CXCR1, CCR2, and CXCR4.
ra Treatment increases the Percentage of 
cD14 expressing cD11c+ Dc
To further evaluate the phenotype of these DC at a protein level, 
we investigated the RA-DC and Mo-DC regarding expression of 
surface proteins associated with DC differentiation, functional 
maturation, and a mucosal DC phenotype. Within the CD11c+ DC 
population, there were marked differences in CD103 and CD1d 
expression between RA-DC and Mo-DC, with significantly 
higher percentages of positive cells among the RA-DC popula-
tion, indicative of a mucosal-DC like phenotype of RA-DC 
(Figures 2A,B). While both types of DC expressed similar per-
centages of HLA-DR, CD83, CD86, and DC-SIGN positive cells 
(Figures 2C–F), there was a markedly higher expression (MFI) 
of these markers in the RA-DC, except for DC-SIGN (Figure 2G 
and Table S2 in Supplementary Material). Notably, the percentage 
of CD14 positive cells in the CD11c+ population was significantly 
higher in the RA-DC (Figure 2H).
ra Treatment induces il10 Production 
and increases secretion of ccr2 ligands, 
but Decreases grO and ccl23
To investigate the influence of RA on the secretory profile of 
these DC, we measured spontaneously secreted cytokine and 
chemokines levels in the RA-DC and Mo-DC culture superna-
tants, with ELISA and chemokine arrays, respectively. TGFβ1 
was highly detected in both types of DC (Figure 3A), while the 
level of IL10 in the RA-DC culture supernatant was significantly 
higher than that of the Mo-DC (Figure 3B). The levels of IL6, 
IL12, IL23, and TNFα were below the detection limit for both 
types of DC (data not shown).
Among 38 chemokines investigated, chemokines such as 
CXCL8, CXCL10, CCL13, CCL3, and CCL5 were constitutively 
detected in both RA-DC and Mo-DC supernatants (Table 1). In 
RA-DC supernatants, CCL2, CCL8, and CCL7 were detected in 
higher intensity, while GRO and two isoform of CCL23 (Ckβ8-1 
and MPIF-1) were detected in lower intensity in comparison to 
Mo-DC.
L. reuteri-cFs has a strong influence on 
gene expression in ra-Dc and Mo-Dc
To elucidate whether postbiotics derived from L. reuteri DSM 
17938 could influence the functional phenotype and secretory 
profile of RA-DC and Mo-DC, we investigated the expression 
of DC-associated genes post-stimulation with L. reuteri-CFS. In 
RA-DC, L. reuteri-CFS induced a strong upregulation of a few 
genes, while most of the investigated genes were downregulated 
in comparison to unstimulated RA-DC (Figure 4A). In contrast, 
the L. reuteri-CFS stimulated Mo-DC showed evenly distributed 
upregulated and downregulated genes in comparison to unstimu-
lated Mo-DC (Figure 4B). Few upregulated genes in L. reuteri-
treated RA-DC were chemokines (CCL5, CXCL1, CXCL2, and 
CXCL8) and cytokines (IL6 and IL10), together with the genes 
for thrombospondin 1 (THBS1) and colony stimulating factor 2 
(CSF2) (Table S3 in Supplementary Material). Gene expression 
for several chemokines (CCL13, CCL19, CXCL10, and IL16), 
chemokine receptors (CCR1, CCR2, CXCR1, and CCR5), and 
molecules involved in antigen presentation and DC-T cell cross 
talk (CD1A, CD1B, CD1C, and CD1D, HLA-DMA, HLA-DPA1, 
CD74, CD40) were downregulated. Lastly, RA-DC stimulated 
with L. reuteri-CFS also downregulated cell adhesion molecules 
(VCAM1, ICAM2, ITGAM, and ITGB2) and transcription fac-
tors (IRF8 and CEBPA).
Mo-DC responded in a partly different way to L. reuteri-CFS 
with an increase in the mRNA expression of molecules associated 
with T cell contact like CD1D, CD80, CD86, and IL12B (encoding 
for the p40 subunit of IL12 and IL23) (Table S3 in Supplementary 
Material). Notably also the expression of FCGR1A (CD64) and 
FCER1A (FcεRI) differed from that of RA-DCs, with a remark-
able up- and down-regulation, respectively.
For comparison, we also evaluated how L. reuteri-CFS 
influenced the gene expression of these two DC populations in 
comparison with LPS, which is frequently used to mature DC.
As depicted in the clustogram, the gene expression profile 
induced by L. reuteri-CFS is distinctly different from that 
FigUre 2 | ra treatment increases the percentage of cD14 expressing cD11c+ Dc. Box plot graphs (a–F) show the percentage of CD11c+ cells 
expressing CD103 (a) CD1d (B), HLA-DR (c), CD83 (D), CD86 (e), and DC-SIGN (F) within the RA-DC and Mo-DC populations at day 6. Representative heat map 
showing MFI fold changes of the surface markers HLA-DR, CD83, CD86, and DC-SIGN of CD11c+ RA-DC in relation the MFI of the Mo-DC is shown in (g).  
(h) shows a box plot graph of percentage of CD14-expressing cells in CD11c+ RA-DCs and Mo-DC. N ≥ 6, ***P < 0.001, **P < 0.01, and *P < 0.05.
FigUre 3 | ra treatment induces il10 production. Spontaneous secretion of TGFβ1 (a) and IL10 (B) in the DC culture supernatants at day 6, as measured by 
ELISA. N = 4–12, ***P < 0.001, **P < 0.01, and *P < 0.05.
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following LPS exposure, and this was most evident for RA-DC 
(Figure  S2 in Supplementary Material). Further, in their 
gene expression profile, the RA-DC show a more dampened 
response to LPS compared to that of the Mo-DC (Figure S3 in 
Supplementary Material).
L. reuteri-cFs Upregulates cD14 and 
Downregulates Dc-sign expression on 
ra-Dc, Without affecting activation 
Markers
We further investigated the effect of L. reuteri-CFS on the 
expression of surface proteins on both RA-DC and Mo-DC. 
L. reuteri-CFS did not influence the expression of CD103, CD1d, 
HLA-DR, or CD83 (Figures  5A–D), while it increased the 
percentage of CD86 positive cells in Mo-DC (Figure  5E). The 
MFI of markers associated with DC activation (HLA-DR, CD83, 
and CD86) increased for Mo-DC treated with L. reuteri-CFS, but 
not for L. reuteri-CFS-treated RA-DC (Figure  5F, Table  S4 in 
Supplementary Material). On the other hand, the percentage of 
DC-SIGN significantly decreased in the RA-DC upon stimula-
tion (Figure 5G). Remarkably, L. reuteri-CFS further increased 
the percentage of CD14+ cells in the RA-DC, without influencing 
that of the Mo-DC (Figure 5H).
L. reuteri-cFs significantly impacts the 
secretory Profile of ra-Dc and Mo-Dc
Lactobacillus reuteri-CFS was potent in inducing IL6, IL23, 
and IL10 by both RA-DC and Mo-DC (Figures  6A–C), while 
TGFβ1 levels did not change with L. reuteri-CFS stimulation 
(Figure 6D).
FigUre 4 | L. reuteri-cFs differentially influences the expression of genes in ra-Dc and Mo-Dc. RT2 PCR arrays were performed on the RNA extracted 
from the RA-DC and Mo-DC treated with L. reuteri-CFS for 24 h. Scatter plots show the fold change of the gene expression of the L. reuteri 17938 treated RA-DC 
(a) and Mo-DC (B) in comparison to culture medium. Upregulated genes are shown in yellow, downregulated genes are shown in blue, and unchanged (less than 
twofold change) genes in black.
TaBle 1 | chemokine (protein) profiling of supernatants from ra-Dc and 
Mo-Dc stimulated with L. reuteri 17938-cFs.
ra-Dc 
medium
ra-Dc  
L. reuteri
Mo-Dc 
medium
Mo-Dc  
L. reuteri
CCL23 + + ++ ++
CCL27 + + + +
CXCL16 + + + +
CXCL5 ++ ++
CCL24 + + + +
CCL26 +
CXCL6 +
GRO + ++ ++ ++
CXCL1 ++ ++
CCL1 ++
CXCL8 ++ ++ ++ ++
CXCL10 + + + +
CCL2 ++ ++ + ++
CCL8 ++ ++ + +
CCL7 ++ ++
CCL13 + + + +
CCL22 + + + +
CCL3 + ++ + ++
CCL4 + + + +
CCL15 + +
CCL20 ++ +
CCL23 ++ +
CXCL7 + + + +
CCL5 ++ ++ ++ +
CCL17 + + + +
+a spot with lower density than reference spots.
++a spot with similar or greater density than reference spots.
Blank space means undetected.
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L. reuteri-CFS induced CXCL1, CXCL5, CCL3, CCL15, 
and CCL20 production in both RA-DC and Mo-DC (Table 1). 
Secreted CCL1 was only detected in Mo-DC after stimulation, 
while CCL7 was only produced in RA-DC but regardless of L. 
reuteri stimulation.
L. reuteri-cFs Upregulates ccr7 
expression on ra-Dc
A hallmark of mucosal DC is the ability of these cells to migrate 
to the mesenteric lymph node (MLN) by upregulating the expres-
sion of CCR7. We investigated CCR7 expression on RA-DC and 
Mo-DC. Although treatment with RA by itself causes increased 
expression of CCR7 (Figure  7A, medium), stimulation with 
L. reuteri-CFS further upregulated the expression of CCR7 
on the RA-DC both in terms of the percentage of positive 
cells (Figure  7A) and level of expression (MFI) [average 1.78 
(1.36–2.26)] (Figure 7B).
ra-Dc-induced FOXP3 and il10 
expression in Treg cells (cD25+ FOXP3+ 
cD4+ cells)
Once mucosal DC migrate to the MLN, they interact with T cells. 
To investigate the influence of the generated DC in terms of their 
ability to promote a Treg response, we cocultured the RA-DC 
and Mo-DC with autologous T cells. For both RA-DC:T cells and 
Mo-DC:T cell cultures, the percentage of Treg cells (CD3+CD4+
CD25+FOXP3+) and/or IL10+ Treg cells were similar (data not 
shown). However, upon coculture with RA-DC, Treg cells had 
an increased expression of FOXP3 and IL10 compared to when 
FigUre 5 | L. reuteri-cFs upregulates cD14 and downregulates Dc-sign expression on ra-Dc. RA-DC and Mo-DC were treated with L. reuteri-CFS  
or LPS or for 24 h. Box plot graphs (a–e) show the percentage of CD11c+ cells expressing CD103 (a), CD1d (B), HLA-DR (c), CD83 (D) and CD86 (e) in  
RA-DCs and Mo-DC post-treatment. Representative heat map showing MFI fold changes of the surface markers HLA-DR, CD83, CD86, and DC-SIGN of  
CD11c+ RA-DC and Mo-DC post-treatment in comparison to culture medium is shown in (F). (g,h) shows the percentages of DC-SIGN+ (g) and CD14+  
(h) CD11c+ cells in RA-DC and Mo-DC populations post-treatment. N ≥ 5, ***P < 0.001, **P < 0.01, and *P < 0.05.
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cocultured with Mo-DC (Figure 8) [FOXP3 MFI average increase 
1.24 (1.08–1.54) and IL10 MFI average increase 1.74 (1.21–2.57) 
for RA-DC:T cell cultures]. Preconditioning of the RA-DC with 
L. reuteri-CFS did not further enhance the Treg response (data 
not shown).
DiscUssiOn
In the human gut, the micro-milieu regulates DC to display a 
tolerogenic phenotype at steady state to prevent an inflammatory 
condition that could disturb the homeostasis. RA is believed to 
be of vital importance in this process, through the induction 
of CD103+ CX3CR1− DC and eventually also Treg cells. Here, 
we generated CD103-expressing mucosal-like DC from human 
peripheral CD14+ monocytes, and thoroughly investigated their 
gene profile, functional- and secretory profile, and interaction 
with T cells. We report significant differences between RA-DC 
and Mo-DC, both on gene- and protein levels, with the RA-DC 
clearly having a more regulatory and tolerogenic profile. Further, 
we describe how L. reuteri DSM 17938-CFS, a commonly used 
probiotic strain, impacts the RA-DC and Mo-DC in different 
ways, adding to the tolerogenic profile of the RA-DC, but with 
little effect on Treg characteristics.
In general only few genes were upregulated in RA-DC 
compared with Mo-DC, while the majority of genes were 
downregulated. Among those genes that were significantly more 
expressed in the RA-DC were IL6 and IL10, confirmed also at 
protein level for IL10. To our knowledge, we are the first to show 
that RA-DC have a constitutive baseline production of IL10 when 
kept in culture medium without continuous RA-supplementation 
during the entire culture period. The expression of a majority of 
the investigated chemokine genes was downregulated in RA-DC, 
possibly indicative of their less pro-inflammatory phenotype. The 
more tolerogenic phenotype of the RA-DC was further supported 
by a reduced expression of TNF and NFκB1 mRNA in RA-DC. 
In addition, the RA-DC had upregulated CCR7 surface expres-
sion, in line with previous findings (22). CCR7 is important for 
CD103+ DC migration to the MLN (4).
In relation to chemokine gene expression, majority of 
chemokines were downregulated in RA-DC. CCL2 and CCL7, 
which are CCR2 ligands, are consistently higher both at protein 
and gene expression level in RA-DC than in Mo-DC. In the gut, 
CCL2 is important to attract CCR2 expressing mononuclear 
phagocytes (23). We hypothesize that the RA-DC-secreted CCL2 
might contribute in the replenishment of phagocytic cells in the 
gut. Since CCR2, at least at the gene expression level, is down-
regulated in RA-DC, we do not consider an autocrine effect of 
CCL2 or CCL7 on the RA-DC very likely. Still, these chemokines 
might be of importance in this environment with a high microbial 
load. CCL2 and CCL7 have been shown to regulate cytokine 
FigUre 7 | L. reuteri-cFs upregulates ccr7 expression on ra-Dc. RA-DC and Mo-DC were treated with L. reuteri-CFS or LPS for 24 h. The box plot graph 
shows the percentage of CCR7 expressing cells in CD11c+ RA-DCs and Mo-DC, post-treatment (a). (B) Representative heat map showing MFI changes of CCR7 
expression in CD11c+ RA-DC and Mo-DC post-treatment, compared to their respective DC in culture medium.
FigUre 6 | L. reuteri-cFs upregulates cytokine production in both ra-Dc and Mo-Dc. RA-DC and Mo-DC were treated with L. reuteri-CFS or LPS for 
24hrs. The production of IL6 (a), IL23 (B), IL10 (c), and TGFb1 (D) from RA-DC and Mo-DC post-treatment was measured by ELISA. N = 4–7, ***P < 0.001, 
**P < 0.01, and *P < 0.05.
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production during infection in the lung and thereby contributing 
to infection control and host resistance (24).
To further explore the different characteristics of the RA-DC 
and Mo-DC, we investigated their response in an inflammatory 
setting. LPS induced expression of multiple genes, mainly in 
Mo-DC. Also, the fold upregulation of gene expression in the 
Mo-DC was much stronger than in RA-DC, giving additional 
support to a more tolerogenic profile of the RA-DC. In addition, 
we investigated the response of the DC types in an inflammatory 
setting. Although L. reuteri-CFS was just as potent as LPS in 
inducing IL10, IL6, and IL23 in both types of DC, the phylogenic 
tree of the clustogram revealed that there was a clear distinction 
FigUre 8 | ra-Dc enhanced FOXP3 expression and il10 production 
in Treg cells (cD25+ FOXP3+ Th cells). T cells were cocultured with 
RA-DC and Mo-DC for 24 h. Representative heat map showing the MFI of 
FOXP3 and IL10 in Treg cells (CD25+ FOXP3+ Th cells) cocultured with 
RA-DC and Mo-DC, respectively. N ≥ 3
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between L. reuteri-CFS and LPS in regulating the expression of 
many DC genes.
IL10 is believed to be a key mediator of a regulatory environ-
ment. In IL10-deficient (25) or IL10 receptor-deficient mice 
(26), the animals develop severe colitis pathology following 
microbial colonization of the gut (27), strongly arguing for a 
regulatory role of IL10 in the gut. Also, in vivo administration 
of the same L. reuteri strain that we used in our study – L. reuteri 
DSM 17938  –  increased IL10 mRNA expression in mice (18). 
Our study support this finding and further indicates that it 
might have been a secreted (postbiotic) factor from L. reuteri 
17938 that played a role in inducing IL10 production in  vivo. 
Indeed, studies on the beneficial effect of secreted factors from 
different lactobacilli on the host immune response are now being 
reported (20). Further support for a beneficial postbiotic effect is 
a very recent report that clearly demonstrates that a heat-killed 
probiotic Lactobacillus strain induced IL10 in peripheral immune 
cells by specifically stabilizing IL-10 mRNA levels, while this was 
not seen with live bacteria of the same strain (28). It has previ-
ously been shown that IL10 dampens IL23 production (29). Here 
however, IL23 is also upregulated in both RA-DC and Mo-DC 
after L. reuteri stimulation. This might appear contradictory to 
lactobacilli-mediated immune regulation as IL23 is mainly linked 
to the development of colitis (30). The downstream signal of IL23 
contributes to the production of IL6 and IL17 (31), but it can also 
contribute to the production of IL22, another cytokine of the IL10 
family (32). IL22 in the gut contributes to the maintenance of epi-
thelial barrier and the induction of antimicrobial peptides, such 
as defensins and lectins (33, 34). In addition, IL23 can mitigate 
deleterious IL12 production by DC and thereby indirectly control 
excessive IFN-γ production by Th1 cells (32), suggesting that this 
IL23 can exert anti-inflammatory effects as well under certain 
circumstances. We also noted a prominent IL6 production after 
L. reuteri stimulation. Given its pleiotropic activity, IL6 can act 
pro-inflammatory but also contributes to intestinal homeosta-
sis. For instance, it plays a major role in microbe-induced IgA 
production and maintenance of Th17 cell population in the gut 
(35, 36). Therefore, L. reuteri-CFS induced production of these 
cytokines could influence the micro-milieu of the gut, supporting 
the balance between tolerogenic responses to innocuous antigens 
and effective responses to infection.
Lactobacillus reuteri-CFS induced the production of several 
chemokines that are involved in gut homeostasis  –  CXCL1, 
CXCL5, CCL3, CCL15, and CCL20 in both RA-DC and Mo-DC. 
Local CXCL5 production regulates steady-state migration of 
neutrophils to the gut. CXCL5−/− mice are devoid of neutrophils 
in the gut and as a consequence produce IL17 in an uncontrolled 
manner (37). CCL15 has been shown to function as an antimi-
crobial peptide in steady state conditions in the gut (38). CXCL1, 
apart from being important component of the intestinal immune 
response, is vital in restoring mucosal barrier integrity in murine 
models (39). In the gut, epithelial cells are the main source of 
CCL3 and CCL20 to recruit mononuclear phagocytes (40). DC 
secreting CCL3 and CCL20 might serve as an additional source 
to keep the gut in homeostasis.
Two other genes were markedly affected by L. reuteri in both 
DC types, namely THBS1 and CSF2, which encode for thrombos-
pondin1 and colony stimulating factor, respectively. Both factors 
are associated with anti-inflammatory activity. Thrombospondin 
1 is an autocrine negative regulator of DC activation, by arresting 
cytokine production that can be induced by microbial stimula-
tion (41). CSF2 is associated with triggering the production of 
regulatory molecules in DC (42, 43).
There were also notable differences in surface marker expres-
sion between the two DC types in relation to L. reuteri-CFS 
exposure. L. reuteri strongly increased the percentage of CD14+ 
cells in the RA-DC, although these cells already had a higher 
CD14+ percentage in the unstimulated condition. CD14 expres-
sion in DC is believed to associate with a tolerogenic phenotype 
(44), in agreement with the more regulatory role of RA-DC but 
also suggesting that L. reuteri is able to support this phenotype. 
How the CD14 expression is induced and how this contributes to 
a more regulatory function is not clear although histamine has 
been shown to induce CD14 expression in DC (45). Indeed, we 
have previously shown a low but detectable histamine production 
by L. reuteri DSM 17938 (21). We have also noticed that L. reuteri-
CFS dampens DC-SIGN mainly on RA-DC. It has been shown 
that lactobacilli can act on DC through DC-SIGN to modulate 
IL10 production by T cells (46).
In order to reach the T cells in the MLN, DC upregulate 
CCR7, which enables them to migrate and encounter T cells 
at the appropriate site. Here, we observed that L. reuteri-CFS 
upregulates CCR7 expression on the surface of RA-DC. Both 
at gene and protein levels, molecules associated with antigen 
presentation and T-cell costimulation were down regulated in the 
RA-DC upon stimulation with L. reuteri-CFS, and often more 
prominently than in Mo-DC. Indeed, tolerogenic-DC express 
low amount of costimulatory molecules and produce high level 
of IL10 (47, 48). The insufficient stimulatory signal for T cells 
from these DC in turn favors T cell-differentiation to Treg (49).
TLR2 expression was upregulated in RA-DC stimulated with 
L. reuteri-CFS, while downregulated in Mo-DC. It has previously 
been shown that TLR2 downstream signaling potently induce 
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